Evidence map›Paper›PMID 36069436›Full record

ArticlemSphere2022

The Molecular Epidemiology of Prevalent Klebsiella pneumoniae Strains and Humoral Antibody Responses against Carbapenem-Resistant K. pneumoniae Infections among Pediatric Patients in Shanghai.

Jie Wang, Ruijing Ma, Fen Pan, Yongqin Wu, Yuqing Pan, Yanan Liu, Fangyuan Yu, Jingran Yu, Heyuan Lun, Yingying Shi and 2 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Risk prediction of carbapenem-resistantFrontiers in cellular and infection microbiology · 2026
    Article
  3. Glycoconjugate Vaccines Against Nosocomial Klebsiella pneumoniae Infections.Advances in experimental medicine and biology · 2026
    Article
  4. Divergent Virulence Traits inInfection and drug resistance · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Jie Wang *Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ruijing Ma *Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Fen Pan *Department of Clinical Laboratory, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yongqin WuDepartment of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yuqing PanDepartment of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yanan LiuDepartment of Clinical Laboratory, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Fangyuan YuDepartment of Clinical Laboratory, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Jingran YuDepartment of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Heyuan LunDepartment of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yingying ShiDepartment of Clinical Laboratory, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Hong ZhangDepartment of Clinical Laboratory, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Ping HeDepartment of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-8005-8119
Shanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant Klebsiella pneumoniae (CRKP) has caused wide dissemination among pediatric patients globally and thus has aroused public concern. Here, we investigated the clinical epidemiological characteristics of 140 nonreplicate clinical K. pneumoniae strains isolated from pediatric patients between January and December 2021. Of all isolates, 16.43% (23 of 140) were CRKP strains, which predominantly contained KPC carbapenemase.

Indexed as

Carbapenem-Resistant EnterobacteriaceaeKlebsiella InfectionsAnti-Bacterial AgentsAntibody FormationCarbapenemsChildChinaHumansImmunoglobulin GKlebsiella pneumoniaeMolecular EpidemiologyPolysaccharidesUronic AcidsAnti-Bacterial AgentsCarbapenemsImmunoglobulin GPolysaccharidesUronic Acidscarbapenem-resistant Klebsiella pneumoniaechildrenCPS-specific antibodyO-genotypingwzi-genotyping

Identifiers

PMID36069436
PMCPMC9599505
OpenAlexW4295860718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.